Phase 1 Evaluation of Unifluvec: Safety and Reactogenicity of an Intranasal Universal Influenza Vector Vaccine at Two Dose Levels
Note: employees of the Institute are marked with an asterisk (*) in the list of authors.
Authors
Stukova* M.A., Zubkova* T.A., Buzitskaya* Zh.V., Shurygina* A-P.S., Erofeeva* M.K., Krokhin A., Ferko B., Nebolsin V., Egorov* A.Yu.
Publication type
Journal article
Indexed in
DOAJ
Info:
Year of publication
2025
Published in
Microbiology Independent Research Journal (MIR Journal)
Volume
12
Number
1
